Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Carcinoma, Lewis Lung

tetradecanoylphorbol acetate has been researched along with Carcinoma, Lewis Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hua, H; Jiang, Z; Li, Y; Liu, Y; Wang, Y; Wang, Z; Zhang, J; Zhu, B1
Aquino, A; Leonetti, C; Tentori, L1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and Carcinoma, Lewis Lung

ArticleYear
High expression of circadian gene mPer2 diminishes radiosensitivity of tumor cells.
    Cancer biotherapy & radiopharmaceuticals, 2008, Volume: 23, Issue:5

    Topics: Animals; Carcinoma, Lewis Lung; Cell Cycle Proteins; Cell Survival; Circadian Rhythm; Cobalt Radioisotopes; DNA Repair; Dose-Response Relationship, Radiation; Gamma Rays; Immunohistochemistry; Mice; Neoplasms; Nuclear Proteins; Period Circadian Proteins; Radiation Tolerance; Reverse Transcriptase Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Transcription Factors

2008
Temozolomide reduces the metastatic potential of Lewis lung carcinoma (3LL) in mice: role of alpha-6 integrin phosphorylation.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:5

    Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Adhesion; Cell Membrane; Dacarbazine; Dose-Response Relationship, Drug; Integrin alpha6; Integrins; Male; Mice; Mice, Inbred C57BL; Naphthalenes; Phosphorylation; Protein Kinase C; Temozolomide; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1995